Donovan, E., Eiriksson, L., Reade, C., Kaur, H., Memon, S., Elit, L. and Kong, I., 2016. Outcomes of Stage IA Serous Endometrial Adenocarcinoma. Brachytherapy, 15, pp.S111-S112.

Donovan, E., Eiriksson, L., Reade, C., Kaur, H., Pond, G., Memon, S., Elit, L. and Kong, I., 2016. 228: Pathologic and Treatment Factors Associated with Recurrence in Stage IA Serous Adenocarcinoma of the Uterus. Radiotherapy and Oncology, 120, p.S83.

Donovan, E., Eiriksson, L., Reade, C., Kaur, H., Memon, S., Pond, G., Elit, L. and Kong, I., 2016. The Pathologic and Treatment Factors Associated With Recurrence in Stage IA Serous Adenocarcinoma of the Uterus. International Journal of Radiation Oncology• Biology• Physics, 96(2), p.E315.

Jimenez, W., Maxwell, J., Daya, D., Sur, M., Elit, L., Eiriksson, L., Reade, C. and Lytwyn, A., 2015.  UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR: IGCS-0060 Uterine Cancer, including Sarcoma. International Journal of Gynecological Cancer, 25, p.69.

Lennox, G.K., Eiriksson, L.R., Reade, C.J., Leung, F., Mojtahedi, G., Atenafu, E.G., Ferguson, S.E., Murphy, J., Diamandis, E.P., Kulasingam, V. and Bernardini, M.Q., 2015. Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter?. International Journal of Gynecological Cancer, 25(5), pp.809-814.

Tsoi, B., Blackhouse, G., Ferrazzi, S., Reade, C.J., Chen, I. and Goeree, R., 2015. Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management. ClinicoEconomics and outcomes research, 7, p.213.

Elit, L. and Reade, C.J., 2015. Recommendations for follow-up care for gynecologic cancer survivors. Obstetrics & Gynecology, 126(6), pp.1207-1214.

Elit, L. and Reade, C.J., 2015. Recomendaciones para la Atención de Seguimiento a Sobrevivientes de Cáncer Ginecológico. Obstet Gynecol, 126, pp.1207-1214.

Covens, A., Vella, E.T., Kennedy, E.B., Reade, C.J., Jimenez, W. and Le, T., 2015. Sentinel lymph node biopsy in vulvar cancer: systematic review, meta-analysis and guideline recommendations. Gynecologic oncology, 137(2), pp.351-361.

Reade, C.J., McVey, R.M., Tone, A.A., Finlayson, S.J., McAlpine, J.N., Fung-Kee-Fung, M. and Ferguson, S.E., 2014. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. Journal of Obstetrics and Gynaecology Canada, 36(2), pp.133-140.

Bouchard-Fortier, G., Reade, C.J. and Covens, A., 2014. Non-radical surgery for small early-stage cervical cancer. Is it time? Gynecologic Oncology, 132(3):624-7.

Reade, C.J., Eiriksson, L.R. and Mackay, H., 2014. Systemic therapy in squamous cell carcinoma of the vulva: current status and future directions. Gynecologic oncology, 132(3), pp.780-789.

Reade, C.J.M., Habiba, U., Eiriksson, L.R., Cesari, M. and Osborne, R.J., 2014. Treatment of low-risk GTN with biweekly actinomycin-D. Gynecologic Oncology, 133, pp.185-186.

Eiriksson, L.R., Millar, H.C., Lennox, G.K., Reade, C.J.M., Leung, F., Diamandis, E.P., Kulasingam, V., Murphy, K.J., Ferguson, S.E. and Bernardini, M.Q., 2014. The usefulness of ovarian cancer risk scoring in the discrimination of an isolated pelvic mass. Gynecologic Oncology, 133, pp.82-83.

Eiriksson, L., Reade, C.J. and Elit, L., 2013. Meeting highlights: International Gynecologic Cancer Society (IGCS 2012). Gynecologic oncology, 128(1), pp.12-14.

Eiriksson, L.R., Reade, C.J., Lennox, G., Mojtahedi, G., Murphy, J., Ferguson, S.E. and Bernardini, M.Q., 2013. Ovarian cancer distribution of histology, stage, and screening performance. Journal of Clinical Oncology, 31,  p.5543.

Reade, C., Tsoi, B., Tanvejsilp, P., Hanson, M., Marcotte, M. and Goeree, R., 2013. A systematic review of economic evaluations on the treatment of ovarian cancer: What have we learned in the past 10 years?. Gynecologic Oncology, 130(1), p.e41.

Reade, C.J., Finlayson, S., McAlpine, J., Tone, A.A., Fung-Kee-Fung, M. and Ferguson, S.E., 2013. Risk- reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists. Journal of Obstetrics and Gynaecology Canada, 35(7), pp.627-634.

Reade, C.J., Riva, J.J., Busse, J.W., Goldsmith, C.H. and Elit, L., 2013. Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis. Gynecologic oncology, 130(3),  pp.674-681.

Reade, C.J., Eiriksson, L.R. and Covens, A., 2013. Surgery for early stage cervical cancer: how radical should it be?. Gynecologic oncology, 131(1), pp.222-230.

Reade, C., Osborne, R., Shah, N., Eiriksson, L., Dodge, J., Moens, F. and Goeree, R., 2013. Treatment of low-risk gestational trophoblastic neoplasia: A probabilistic decision analysis model. Gynecologic Oncology, 130(1), pp.e27-e28.

Reade, C.J., Riva, J.J., Busse, J.W., Goldsmith, C.H. and Elit, L., 2013. Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis. Gynecologic oncology, 130(3),  pp.674-681.

J Reade, C., R Eiriksson, L. and Covens, A., 2012. A review of surgical options to preserve fertility in the treatment of early cervical cancer. Current Women's Health Reviews, 8(3), pp.219-230.

Reade, C.J., Jimenez, W., O’Reilly, D. and Covens, A., 2012. Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context. Journal of Obstetrics and Gynaecology Canada, 34(11), pp.1053-1065.

Reade, C. and Elit, L., 2012. Trends in gynecologic cancer care in North America. Obstetrics and gynecology clinics of North America, 39(2), pp.107-129.

Reade, C., Hauspy, J., Schmuck, M.L. and Moens, F., 2011. Characterizing the learning curve for laparoscopic radical hysterectomy: buddy operating as a technique for accelerating skill acquisition. International Journal of Gynecological Cancer, 21(5), pp.930-935.